Aerobit is a smart inhaler, a tool for tracking medication use that records each time inhalers are taken and comes in a variety of cool toy designs. Built in sensors can even tell if the inhaler has been shaken correctly.
days to go:
Expired
investment:
£116,960
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go:
Expired
investment:
Withheld
Glovebox Direct is an online automotive parts, accessories and merchandise marketplace selling original equipment direct from the car and bike brands.
days to go:
Expired
investment:
£181,670
Endlesss is a cloud-connected mobile and desktop app that turns music creation into a live, collaborative social event where musicians and fans can interact in real-time from anywhere in the world. The company argues that despite users making music, sharing that piece of music is a long and lonely process that takes days or months, requires multiple different apps and services, and carries no guarantee on whether those songs would be heard or not. Endlesss aims to change this via its software. The company witnessed over 9,000 sign-ups in May 2021, oversaw over 40,000 jams and 2.6 million riffs being created in 2020, and has spread across 100+ countries. Endlesss aspires to dominate the music creation software market that is expected to grow to $1.86 billion by 2027, up from $884 million in 2020. The company has received acclaim from entities such as Verge, TechCrunch and Pitchfork. Endlesss states it will use the investment to grow its team, develop new features, boost marketing, and promote Research & Development (R&D) to grow its business.
days to go:
Expired
investment:
£415,541
HouseStars is a comprehensive property maintenance application powered by AI, enabling convenient connections between property owners and various trade professionals, such as builders, plumbers, electricians, and gas engineers. With this app, property upkeep is simplified - you can choose a service provider based on their ratings, select a suitable date and time, engage in communication, leave reviews, and complete secure payments through an escrow system, all through your mobile device.
days to go:
Expired
investment:
£162,203
Viritech is a clean technology engineering company that is using F1-derived engineering to develop hydrogen powertrain solutions and related technologies for the automotive, aerospace, marine and distributed power industries. Viritech asserts that the Hydrogen Council forecasts that hydrogen will meet 18% of global energy demand by 2050. It aims to capture this demand through its technologies. Viritech argues that its location in MIRA Technology Park allows it access to R&D facilities used by many of the world's major automotive manufacturers, allowing it to scale its resources to meet the demands of every type of project. Viritech will use the investment to produce test hydrogen tanks, build the Apricale hypercar, complete designs for a Heavy Goods Vehicle (HGV), Sport Utility Vehicle (SUV) and a power generator, plan a larger raise and listing on AQuis Stock Exchange (AQSE) in 2022, and eventually commercialise its technology with its partner.
days to go:
Expired
investment:
£726,807
Trecento Diagnostics, with the help of a molecular testing system complete, they are now ready to launch a patent-pending collection device named HygieCatch®. It is a non-invasive, needle-free examination, in the vet practice providing DNA extraction from urine onsite with a report within 40 minutes of extraction of the sample. The company has identified partners in the UAE and US and is also in early-stage discussions with UK vet practices. Furthermore, for the purpose of commercialisation of HygieCatch & the technology used, alongside addition of new tests including Lyme disease the company is planning to raise its capital.
days to go:
Expired
investment:
£167,910
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.
days to go:
Expired
investment:
£148,736
A medical condition management platform allowing clinicians to create their own app to improve a patient's health whilst reducing costs. Living With develops smart apps specific to a person's condition, they currently have 3 products with another in the development stage. Their primary app, Squeezy, is the top paid medical app in the UK that helps patients with their pelvic floor exercises. Other apps, allow clinicians to monitor a patient's bowel and bladder health, as well as those with rheumatoid arthritis. These apps are already in use at multiple NHS Trusts and clinics.
Funds are being raised to complete development of their apps to help those with lupus and lung cancer, in addition to further developing their existing products. The company aims to have thousands of apps that will be available worldwide to provide self-service treatment at any time. Living With is expecting to earn £1.07m in revenue by the end of March 2019.
days to go:
Expired
investment:
£250,000
Riversimple is a car manufacturer and service provider that is spearheading ‘next-generation’ Hydrogen electric vehicles. It sells mobility as a service and retains ownership of its cars. Their pricing structure allows customers to pay a single monthly fee that covers the vehicle, fuel, maintenance, and insurance costs. It's proprietary offering, Rasa, is a two-seat local commuter vehicle that can achieve a 250mpg equivalent fuel figure with a 300-mile range from a 3-minute fill. The company has recently been awarded two new grants from The Office for Low Emission Vehicles (OLEV) for £1.25 million to support the build of its first low volume production run, and another from InnovateUK worth £0.5 million to support the deployment of cars in the Milford Haven Energy Kingdom project. The company has also been featured in several prominent publications such as The Guardian, CNBC, BBC Wales, Reuters and CNN to name a few. The company will use the investment to expand its engineering team and start volume production to reach product commercialisation by the end of 2022.
days to go:
Expired
investment:
£504,000
